Big Pharma Pays $3.5B/Year to Keep Your Meds Expensive

What if a big company paid its competitors to stay out of the market? That's illegal in most industries. In the pharmaceutical world, it's just Tuesday.

What Is a Pay-for-Delay Deal?

Here's how it works. A brand-name drug company holds a patent on a medication. A generic manufacturer wants to sell a cheaper version. Instead of competing, the brand-name company pays the generic manufacturer to stay off the market.

These agreements are called pay-for-delay deals. And they are widespread.

The Federal Trade Commission estimates these deals cost American consumers $3.5 billion every single year in higher drug prices. That's not a rounding error. That's a deliberate strategy to protect profits at your expense.

The Supreme Court and Congress Looked the Other Way

In 2013, the Supreme Court had a chance to shut this down. It mostly didn't. The court allowed these deals to continue as long as they passed a loose antitrust review. That left a wide-open door for Big Pharma to keep paying competitors to do nothing.

What about Congress? They could pass laws to stop this. But there's a reason they haven't.

PhRMA — the pharmaceutical industry's main lobbying group — spent nearly $38 million lobbying Congress in 2025. The industry employs over 1,400 federal lobbyists. There are only 535 members of Congress. Do the math. That's more than two lobbyists for every single elected representative.

This isn't a free market. It's a protected racket.

Your Employees Pay the Price

Every time one of your employees fills a prescription, they may be paying an inflated price — not because the drug is hard to make, but because a backroom deal kept the cheaper version off the shelf.

High drug costs hit small businesses especially hard. You don't have the purchasing power of a Fortune 500 company. You can't negotiate bulk pricing. So your employees absorb the cost, or you do when premiums rise to cover it.

What Small Businesses Can Do Right Now

You can't fix Congress. But you can build a benefits strategy that doesn't depend on a broken system.

That's exactly what ICHRA — the Individual Coverage Health Reimbursement Arrangement — is designed to do. Instead of locking your employees into one expensive group plan, ICHRA lets you set a defined contribution amount. Each employee shops for their own individual health insurance and gets reimbursed up to that amount.

Pair that with an indemnity plan option for employees who opt out of the ICHRA. Indemnity plans have no deductibles or copays. That means employees have a real financial reason to shop around — including for prescriptions. When they find lower-cost care or cheaper meds, they keep the difference. That's how you create smart healthcare consumers.

The pharmaceutical industry has rigged the rules in its favor. But small business owners don't have to play by those rules when it comes to how they structure employee benefits.

Fight Back With Smarter Benefits

At The Benefit X-Change, we help small businesses offer real, affordable health benefits — without handing Big Pharma a blank check. We administer ICHRAs and offer indemnity plan options so your employees have choices and you stay in control of your costs.

Ready to stop overpaying? Visit benefitx.com and see how we can help.